A securities fraud class action lawsuit has been filed against GeneDx Holdings Corp. on behalf of investors who purchased or acquired WGS common stock between April 16, 2025, and May 4, 2026. The lawsuit alleges that the company made materially false and misleading statements and failed to disclose significant problems with the viability of its acquisition of Fabric Genomics. On May 4, 2026, GeneDx announced first quarter results that included a $31.3 million impairment loss directly attributable to Fabric, which was only $5.2 million less than the upfront cash paid for the acquisition a year prior, causing the share price to fall more than 49%. Investors have until August 3, 2026, to file for lead plaintiff status in the case, which is pending in the United States District Court for the District of Connecticut.
GeneDx Holdings Corp.lawsuit alleges misleading statements about Fabric Genomics acquisition, leading to $31.3M impairment and 49% stock drop
ServiceNow Inc